Shares of biotech Replimune Group sank more than 19% after the Food and Drug Administration rejected an application seeking ...

Vishnu Tripathi develops reagents and assays to advance clinical care and research diagnostics.

Three years after its OrbiMed-backed series A in 2023, Sidewinder Therapeutics is adding to its nest egg courtesy of a clutch ...

The FDA in a complete response letter to Replimune maintained its original objection to the single-arm trial the biotech used ...

DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced ...

Replimune Group criticized a Food and Drug Administration decision to deny its application for a melanoma treatment in a review process that the clinical-stage biotechnology company said was marked by ...

The FDA advised IO Biotech last year to hold off on filing an approval application for its cancer vaccine Cylembio, pointing ...

MIT Technology Review discovered that the stealth startup’s founder John Schloendorn also pitched a startling, medically ...

Treprostinil is a potent drug for various lung diseases because it opens blood vessels, reduces lung scarring, inhibits ...

Leveraging its PharmaPatch™ experience, the Company is introducing PatchPrint™ to support existing microneedle patch programs and expand into on-demand personalized patch solutions, including peptide ...

Jawaharlal Nehru University on Thursday issued its e-prospectus for admissions to undergraduate, postgraduate, PG Diploma and ...

Standing Ovation raises $34.2 million to scale up its breakthrough technology for producing dairy proteins through precision ...